POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Potassium Chloride 40meq In Dextrose 5% And Sodium Chloride 0.9%, and what generic alternatives are available?
Potassium Chloride 40meq In Dextrose 5% And Sodium Chloride 0.9% is a drug marketed by Fresenius Kabi Usa, Baxter Hlthcare, and Icu Medical Inc. and is included in three NDAs.
The generic ingredient in POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% is dextrose; potassium chloride; sodium chloride. There are nine drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dextrose; potassium chloride; sodium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%?
- What are the global sales for POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%?
- What is Average Wholesale Price for POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%?
Summary for POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 3 |
Formulation / Manufacturing: | see details |
DailyMed Link: | POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% at DailyMed |
![POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9% drug patent expirations Drug patent expirations by year for POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%](/p/graph/s/t/POTASSIUM_CHLORIDE_40MEQ_IN_DEXTROSE_5%_AND_SODIUM_CHLORIDE_0.9%-patent-expirations.png)
Pharmacology for POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.9%
Drug Class | Osmotic Laxative Potassium Salt |
Mechanism of Action | Osmotic Activity |
Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption |